ÒÎÐ 5 ñòàòåé: Ìåòîäè÷åñêèå ïîäõîäû ê àíàëèçó ôèíàíñîâîãî ñîñòîÿíèÿ ïðåäïðèÿòèÿ Ïðîáëåìà ïåðèîäèçàöèè ðóññêîé ëèòåðàòóðû ÕÕ âåêà. Êðàòêàÿ õàðàêòåðèñòèêà âòîðîé ïîëîâèíû ÕÕ âåêà Õàðàêòåðèñòèêà øëèôîâàëüíûõ êðóãîâ è åå ìàðêèðîâêà Ñëóæåáíûå ÷àñòè ðå÷è. Ïðåäëîã. Ñîþç. ×àñòèöû ÊÀÒÅÃÎÐÈÈ:
|
Õ³ðóðã³÷íå âòðó÷àííÿ ó ïàö³ºíò³â, ÿê³ ïðîõîäÿòü àíòèòðîìáîöèòàðíó òåðàï³þ 3 ñòðàíèöà114. Zeymer U, Uebis R, Vogt A, Glunz HG, Vohringer HF, Harmjanz D, Neuhaus KL Randomized comparison of percutaneous transluminal coronary angioplasty andmedical therapy in stable survivors of acute myocardial infarction with singlevessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte Circulation 2003;108(11):1324–1328 115. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S,RuzylloW, Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP,Steg PG, Mascette AM, Sopko G, Pfisterer ME, Leor J, Fridrich V, Mark DB,Knatterud GL. Coronary intervention for persistent occlusion after myocardial infarction N Engl J Med 2006;355(23):2395–2407 116. Nishigaki K, Yamazaki T, Kitabatake A, Yamaguchi T, Kanmatsuse K, Kodama I,Takekoshi N, Tomoike H, Hori M, Matsuzaki M, Takeshita A, Shimbo T,Fujiwara H. Percutaneous coronary intervention plus medical therapy reducesthe incidence of acute coronary syndrome more effectively than initial medicaltherapy only among patients with low-risk coronary artery disease a randomized,comparative, multicenter study. JACC Cardiovasc Interv 2008;1(5):469–479 117. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronaryangioplasty vs. medical treatment for non-acute coronary heart disease:meta-analysis of randomised controlled trials. BMJ 2000;321(7253):73–77 118. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention vs. conservativetherapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005;111(22):2906–2912 119. Schomig A, Mehilli J, deWaha A, Seyfarth M, Pache J, Kastrati A. A meta-analysis of17 randomized trials of a percutaneous coronary intervention-based strategy inpatients with stable coronary artery disease. J Am Coll Cardiol 2008;52(11):894–904 120. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM. Percutaneouscoronary interventions for non-acute coronary artery disease: a quantitative20-year synopsis and a network meta-analysis. Lancet 2009;373(9667):911–918 121. Hannan EL, Samadashvili Z, Cozzens K, Walford G, Jacobs AK, Holmes DR Jr.,Stamato NJ, Gold JP, Sharma S, Venditti FJ, Powell T, King SB 3rd. Comparative outcomesfor patients who do and do not undergo percutaneous coronary interventionfor stable coronary artery disease in New York. Circulation 2012;125(15):1870–1879 121a. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, Voigt JU, Zamorano JL. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008;9(415–437. 122. Shaw LJ,Weintraub WS, Maron DJ, Hartigan PM, Hachamovitch R, Min JK, Dada M,Mancini GB, Hayes SW, O’Rourke RA, Spertus JA, Kostuk W, Gosselin G,Chaitman BR, Knudtson M, Friedman J, Slomka P, Germano G, Bates ER, Teo KK,Boden WE, Berman DS. Baseline stress myocardial perfusion imaging results andoutcomes in patients with stable ischemic heart disease randomized to optimalmedical therapy with or without percutaneous coronary intervention. Am HeartJ 2012;164(2):243–250 123. Stergiopoulos K, Brown DL. Initial coronary stent implantation with medicaltherapy vs.medical therapy alone for stable coronary artery disease: meta-analysisof randomized controlled trials. Arch Intern Med 2012;172(4):312–319 124. Stettler C,Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, Pfisterer ME,StoneGW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabate M, Suttorp MJ, Kelbaek H,Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS,Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S,Windecker S, Juni P. Outcomes associated with drug-eluting and bare-metalstents: a collaborative network meta-analysis. Lancet 2007;370(9591):937–948 125. Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J Short- and long-term outcomes with drug-eluting and bare-metal coronary stents:a mixed-treatment comparison analysis of 117 762 patient-years of follow-up fromrandomized trials. Circulation 2012;125(23):2873–2891 126. Dangas GD, SerruysPW, Kereiakes DJ, Hermiller J, Rizvi A, NewmanW, Sudhir K,Smith RS Jr., Cao S, Theodoropoulos K, Cutlip DE, Lansky AJ, Stone GW Meta-analysis of everolimus-eluting vs. paclitaxel-eluting stents in coronaryartery disease: final 3-year results of the SPIRIT clinical trials program (ClinicalEvaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatmentof Patients With De Novo Native Coronary Artery Lesions). JACC CardiovascInterv 2013;6(9):914–922 126a. Imbert L, Poussier S, Franken PR, Songy B, Verger A, Morel O, Wolf D, Noel A, Karcher G, Marie PY. Compared performance of high-sensitivity cameras dedicated to myocardial perfusion SPECT: a comprehensive analysis of phantom and human images. J Nucl Med 2012;53:1897–1903. 127. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, deWaha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J,Kovacic J, Kini AS, Dangas GD. Impact of the everolimus-eluting stent on stentthrombosis: a meta-analysis of 13 randomized trials. J Am Coll Cardiol 2011;58(15):1569–1577 128. Stefanini GG, Byrne RA, Serruys PW, de Waha A, Meier B, Massberg S, Juni P,Schomig A, Windecker S, Kastrati A. Biodegradable polymer drug-eluting stentsreduce the risk of stent thrombosis at 4 years in patients undergoing percutaneouscoronary intervention: a pooled analysis of individual patient data from theISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. Eur Heart J 2012;33(10):1214–1222 129. Stefanini GG, Baber U, Windecker S, Morice MC, Sartori S, Leon MB, Stone GW,SerruysPW, WijnsW,Weisz G, Camenzind E, Steg PG, Smits PC, Kandzari D, VonBirgelen C, Galatius S, Jeger RV, Kimura T, Mikhail G, Itchhaporia D, Mehta L,Ortega R, Kim HS, Valgimigli M, Kastrati A, Chieffo A, Mehran R. Safety and efficacyof drug-eluting stents in women: a patient-level pooled analysis of randomisedtrials. Lancet 2013;382(9908):1879–1888 130. Stefanini GG, Kalesan B, Serruys PW, Heg D, Buszman P, Linke A, Ischinger T,Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D,Sohn HY, Eerdmans P, van Es GA, Meier B, Windecker S, Juni P. Long-term clinicaloutcomes of biodegradable polymer biolimus-eluting stents vs. durable polymersirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4year follow-up of a randomised non-inferiority trial. Lancet 2011;378(9807):1940–1948 131. Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D’Ascenzo F,Kimura T, Briguori C, Sabate M, Kim HS, De Waha A, Kedhi E, Smits PC,Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, StoneGW. Stent thrombosiswith drug-eluting and bare-metal stents: evidence from a comprehensive networkmeta-analysis. Lancet 2012;379(9824):1393–1402 132. Bangalore S, Toklu B, Amoroso N, Fusaro M, Kumar S, Hannan EL, FaxonDP, Feit F Bare metal stents, durable polymer drug eluting stents, and biodegradable polymerdrug eluting stents for coronary artery disease: mixed treatment comparisonmeta-analysis. BMJ 2013;347:f6625 133. Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, Pedrazzini G, Hornig B,Bertel O, Bonetti P, De Servi S, Brunner-La Rocca HP, Ricard I, Pfisterer M Drug-eluting vs. bare-metal stents in large coronary arteries. N Engl J Med 2010;363(24):2310–2319 134. Bittl JA, He Y, Jacobs AK, YancyCW, Normand SL. Bayesian methods affirm the useof percutaneous coronary intervention to improve survival in patients with unprotectedleft main coronary artery disease. Circulation 2013;127(22):2177–2185 135. Dzavik V, GhaliWA, Norris C, Mitchell LB, Koshal A, Saunders LD, Galbraith PD,HuiW, Faris P, Knudtson ML. Long-term survival in 11,661 patients withmultivesselcoronary artery disease in the era of stenting: a report from the Alberta ProvincialProject forOutcome Assessment in CoronaryHeart Disease(APPROACH)Investigators Am Heart J 2001;142(1):119–126 136. Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER, Lilly RE, SketchMHJr.,Peterson ED, Jones RH. Selection of surgical or percutaneous coronary interventionprovides differential longevity benefit. Ann Thorac Surg 2006;82(4):1420–1428;discussion 1428–1429 137. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, Higgins RS,Carlson RE, Jones RH. Drug-eluting stents vs. coronary-artery bypass grafting inmultivessel coronary disease. N Engl J Med 2008;358(4):331–341 138. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, Taylor HA,Chaitman BR. Comparison of surgical and medical group survival in patients withleft main equivalent coronary artery disease. Long-term CASS experience. Circulation1995;91(9):2335–2344 139. Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, Sopko G,Ramires JA, Schneider D, Frye RL, Bypass Angioplasty RevascularizationInvestigation 2 Diabetes Study G. The Bypass Angioplasty Revascularization Investigation2 Diabetes randomized trial of different treatment strategies in type 2 diabetesmellitus with stable ischemic heart disease: impact of treatment strategy oncardiac mortality and myocardial infarction. Circulation 2009;120(25):2529–2540 140. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary arterybypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985;312(26):1665–1671 141. Jones RH, Kesler K, Phillips HR 3rd, Mark DB, Smith PK, Nelson CL, Newman MF,Reves JG, AndersonRW, Califf RM. Long-term survival benefits of coronary arterybypass grafting and percutaneous transluminal angioplasty in patients with coronaryartery disease. J Thorac Cardiovasc Surg 1996;111(5):1013–1025 142. BakerDW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management ofheart failure. III. The role of revascularization in the treatment of patients with moderateor severe left ventricular systolic dysfunction. JAMA 1994;272(19):1528–1534 143. Hachamovitch R, HayesSW, Friedman JD, Cohen I, Berman DS. Comparison of theshort-term survival benefit associated with revascularization compared withmedical therapy in patients with no prior coronary artery disease undergoingstress myocardial perfusion single photon emission computed tomography. Circulation2003;107(23):2900–2907 144. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, Sopko G,Pratt C, Deanfield J, Conti CR. Asymptomatic Cardiac Ischemia Pilot (ACIP) studytwo-year follow-up: outcomes of patients randomized to initial strategies ofmedical therapy vs. revascularization. Circulation 1997;95(8):2037–2043 145. Thomas S, Gokhale R, Boden WE, Devereaux PJ. A meta-analysis of randomizedcontrolled trials comparing percutaneous coronary intervention with medicaltherapy in stable angina pectoris. Can J Cardiol 2013;29(4):472–482 146. Coronary angioplasty vs. coronary artery bypass surgery: the Randomized InterventionTreatment of Angina (RITA) trial. Lancet 1993;341(8845):573–580 147. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomizedstudy of coronary angioplasty compared with bypass surgery in patientswith symptomatic multivessel coronary disease. German Angioplasty BypassSurgery Investigation (GABI). N Engl J Med 1994;331(16):1037–1043 148. King SB 3rd, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH,AlazrakiNP, Guyton RA, ZhaoXQ.A randomized trial comparing coronary angioplastywith coronary bypass surgery. Emory Angioplasty vs. Surgery Trial (EAST).NEngl J Med 1994;331(16):1044–1050 149. First-year results of CABRI (Coronary Angioplasty vs. Bypass Revascularisation Investigation) CABRI Trial Participants. Lancet 1995;346(8984):1179–1184 150. Comparison of coronary bypass surgery with angioplasty in patients with multivesseldisease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators N Engl J Med 1996;335(4):217–225 150a. Halliburton S, Arbab-Zadeh A, Dey D, Einstein AJ, Gentry R, George RT, Gerber T, Mahesh M,Weigold WG. State-of-the-art in CT hardware and scan modes for cardiovascular CT. J Cardiovasc Comput Tomogr 2012;6:154–163. 151. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R,Ramanathan K, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S,Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D,Barbiere C, Lewis D, Angina With Extremely Serious Operative Mortality E. Percutaneouscoronary intervention vs. coronary artery bypass graft surgery for patientswith medically refractory myocardial ischemia and risk factors for adverse outcomeswith bypass: a multicenter, randomized trial. Investigators of the Departmentof Veterans Affairs Cooperative Study #385, the Angina With ExtremelySerious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol 2001;38(1):143–149 151a. Hausleiter J, Martinoff S, Hadamitzky M, Martuscelli E, Pschierer I, Feuchtner GM, Catalan-Sanz P, Czermak B, Meyer TS, Hein F, Bischoff B, Kuse M, Schomig A, Achenbach S. Image quality and radiation exposure with a low tube voltage protocol for coronary CT angiography results of the PROTECTION II Trial. JACC Cardiovasc Imaging 2010;3:1113–1123. 152. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J, Vogel D, Grinfeld R,Delacasa A, Garrido M, Oliveri R, Mele E, Palacios I, O’NeillW. Argentine RandomizedStudy: Coronary Angioplasty with Stenting vs. Coronary Bypass Surgery inpatients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-upresults. ERACI II Investigators. J Am Coll Cardiol 2001;37(1):51–58 153. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N,Bonser R, van den Brand MJ, van Herwerden LA, MorelMA, van Hout BA. Comparisonof coronary-artery bypass surgery and stenting for the treatment of multivesseldisease. N Engl J Med 2001;344(15):1117–1124 154. Coronary artery bypass surgery vs. percutaneous coronary intervention with stentimplantation in patients with multivessel coronary artery disease (the Stent orSurgery trial): a randomised controlled trial. Lancet 2002;360(9338):965–970 155. Eefting F, Nathoe H, van Dijk D, Jansen E, Lahpor J, Stella P, SuykerW, Diephuis J,Suryapranata H, Ernst S, Borst C, Buskens E, Grobbee D, de Jaegere P. Randomizedcomparison between stenting and off-pump bypass surgery in patients referred forangioplasty. Circulation 2003;108(23):2870–2876 155a. Brodoefel H, Burgstahler C, Tsiflikas I, Reimann A, Schroeder S, Claussen CD, Heuschmid M, Kopp AF. Dual-source CT: effect of heart rate, heart rate variability, and calcification on image quality and diagnostic accuracy. Radiology 2008;247: 346–355. 156. Thiele H, Oettel S, Jacobs S, Hambrecht R, Sick P, Gummert JF, Mohr FW,Schuler G, Falk V. Comparison of bare-metal stenting with minimally invasivebypass surgery for stenosis of the left anterior descending coronary artery: a5-year follow-up. Circulation 2005;112(22):3445–3450 156a. Chen CC, Chen CC, Hsieh IC, Liu YC, LiuCY, ChanT,Wen MS,Wan YL. The effect of calcium score on the diagnostic accuracy of coronary computed tomography angiography. Int J Cardiovasc Imaging 2011;27 Suppl 1:37–42. 157. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ,Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K,Dawkins KD, Mohr FW. Percutaneous coronary intervention vs. coronary-arterybypass grafting for severe coronary artery disease. N Engl J Med 2009;360(10):961–972 158. Boudriot E, Thiele H,Walther T, Liebetrau C, Boeckstegers P, Pohl T, Reichart B,Mudra H, Beier F, Gansera B, Neumann FJ, Gick M, Zietak T, Desch S, Schuler G,Mohr FW. Randomized comparison of percutaneous coronary intervention withsirolimus-eluting stents vs. coronary artery bypass grafting in unprotected leftmain stem stenosis. J Am Coll Cardiol 2011;57(5):538–545 159. Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, Lee JY, Kim WJ, Kang SJ,Lee SW, Lee CW, Park SW, Chung CH, Lee JW, Lim DS, Rha SW, Lee SG,Gwon HC, Kim HS, Chae IH, Jang Y, Jeong MH, Tahk SJ, Seung KB. Randomizedtrial of stents vs. bypass surgery for left main coronary artery disease. N Engl JMed 2011;364(18):1718–1727 160. Kapoor JR, Gienger AL, Ardehali R, Varghese R, Perez MV, Sundaram V,McDonald KM, Owens DK, Hlatky MA, Bravata DM. Isolated disease of the proximalleft anterior descending artery comparing the effectiveness of percutaneouscoronary interventions and coronary artery bypass surgery. JACC CardiovascInterv 2008;1(5):483–491 161. Aziz O, Rao C, Panesar SS, Jones C, Morris S, Darzi A, Athanasiou T. Meta-analysisof minimally invasive internal thoracic artery bypass vs. percutaneous revascularisationfor isolated lesions of the left anterior descending artery. BMJ 2007;334(7594):617 162. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW,Golding LA, Gill CC, Taylor PC, Sheldon WC et al. Influence of theinternal-mammary-artery graft on 10-year survival and other cardiac events. NEngl J Med 1986;314(1):1–6 163. Cameron A, Davis KB, Green GE, Myers WO, Pettinger M. Clinical implications ofinternal mammary artery bypass grafts: the Coronary Artery Surgery Study experience Circulation 1988;77(4):815–819 164. Lytle BW, Blackstone EH, Sabik JF, Houghtaling P, Loop FD, Cosgrove DM. Theeffect of bilateral internal thoracic artery grafting on survival during 20 postoperativeyears. Ann Thorac Surg 2004;78(6):2005–2012; discussion 2012–2014 165. Kurlansky PA, Traad EA, Dorman MJ, Galbut DL, Zucker M, Ebra G. Thirty-yearfollow-up defines survival benefit for second internal mammary artery inpropensity-matched groups. Ann Thorac Surg 2010;90(1):101–108 166. Taggart DP, Kaul S, Boden WE, Ferguson TB Jr., Guyton RA, Mack MJ, Sergeant PT,Shemin RJ, Smith PK, Yusuf S. Revascularization for unprotected left main stem coronaryartery stenosis stenting or surgery. J Am Coll Cardiol 2008;51(9):885–892 167. Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M,Massberg S, Laugwitz KL, Dirschinger J, Schomig A. Paclitaxel- vs. sirolimus-elutingstents for unprotected left main coronary artery disease. J Am Coll Cardiol 2009;53(19):1760–1768 168. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A,Mack MJ, Holmes DR, Torracca L, van Es GA, Leadley K, Dawkins KD, Mohr F. Outcomesin patients with de novo left main disease treated with either percutaneouscoronary intervention using paclitaxel-eluting stents or coronary artery bypassgraft treatment in the Synergy Between Percutaneous Coronary Interventionwith TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010;121(24):2645–2653 169. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A,Mack MJ, Holmes DR, Choi JW, Ruzyllo W, Religa G, Huang J, Roy K,Dawkins KD, Mohr F. Five-Year Outcomes in Patients with Left Main DiseaseTreated with Either Percutaneous Coronary Intervention or Coronary ArteryBypass Grafting in the SYNTAX Trial. Circulation 2014;129:2388–2394 170. Capodanno D, StoneGW, Morice MC, Bass TA, Tamburino C. Percutaneous coronaryintervention vs. coronary artery bypass graft surgery in left main coronaryartery disease: a meta-analysis of randomized clinical data. J Am Coll Cardiol 2011;58(14):1426–1432 170a. Kato S, Kitagawa K, Ishida N, Ishida M, Nagata M, Ichikawa Y, Katahira K, Matsumoto Y, Seo K, Ochiai R, Kobayashi Y, Sakuma H. Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial. J Am Coll Cardiol 2010;56:983–991. 171. Buszman PE, Buszman PP, Kiesz RS, Bochenek A, Trela B, Konkolewska M,Wallace-Bradley D, Wilczynski M, Banasiewicz-Szkrobka I, Peszek-Przybyla E,Krol M, Kondys M, Milewski K, Wiernek S, Debinski M, Zurakowski A, Martin JL,Tendera M. Early and long-term results of unprotected left main coronary arterystenting: the LE MANS (Left Main Coronary Artery Stenting) registry. J Am CollCardiol 2009;54(16):1500–1511 172. Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ,Choo SJ, Chung CH, Lee JW, ParkSW, Park SJ. Long-term outcomes after stentingvs. coronary artery bypass grafting for unprotected left main coronary arterydisease: 10-year results of bare-metal stents and 5-year results of drug-elutingstents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization)Registry. J Am Coll Cardiol 2010;56(17):1366–1375 172a. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501–2555. 173. Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Coronary Artery Bypass Graftingvs.Percutaneous Coronary Intervention and Long-term Mortality and Morbidity inMultivessel Disease: Meta-analysis of Randomized Clinical Trials of the ArterialGrafting and Stenting Era. JAMA Intern Med 2014;174(2):223–230 174. Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez MV, Varghese R,Kapoor JR, Ardehali R, OwensDK, Hlatky MA. Systematic review: the comparativeeffectiveness of percutaneous coronary interventions and coronary artery bypassgraft surgery. Ann Intern Med 2007;147(10):703–716 175. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M,Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA,Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J,Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd,Bertrand M, Fuster V, Investigators FT. Strategies for multivessel revascularizationin patients with diabetes. N Engl J Med 2012;367(25):2375–2384 176. Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ,Morice MC, Holmes DR, Feldman TE, Staehle E, Underwood P, Dawkins KD,Kappetein AP, Mohr FW. Coronary artery bypass grafting vs. percutaneouscoronary intervention for patients with three-vessel disease: final five-year followupof the SYNTAX trial. Eur Heart J. Published online 21 May 2014; doi: 10.1093/eurheartj/ehu213 177. Wu C, Camacho FT, Zhao S, Wechsler AS, Culliford AT, Lahey SJ, King SB 3rd,Walford G, Gold JP, Smith CR, Jordan D, Higgins RS, Hannan EL. Long-term mortalityof coronary artery bypass graft surgery and stenting with drug-eluting stents Ann Thorac Surg 2013;95(4):1297–1305 178. Blazek S, Holzhey D, Jungert C, Borger MA, Fuernau G, Desch S, Eitel I, deWaha S,Lurz P, Schuler G, Mohr FW, Thiele H. Comparison of bare-metal stenting withminimally invasive bypass surgery for stenosis of the left anterior descending coronaryartery: 10-year follow-up of a randomized trial. JACC Cardiovasc Interv 2013;6(1):20–26 179. Thiele H, Neumann-Schniedewind P, Jacobs S, Boudriot E,Walther T, Mohr FW,Schuler G, Falk V. Randomized comparison of minimally invasive direct coronaryartery bypass surgery vs. sirolimus-eluting stenting in isolated proximal left anteriordescending coronary artery stenosis. J Am Coll Cardiol 2009;53(25):2324–2331 180. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D,Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF,WijnsW, Zahger D, Guidelines ESCCfP. ESC Guidelines for the management ofacute coronary syndromes in patients presenting without persistent ST-segmentelevation: The Task Force for the management of acute coronary syndromes(ACS) in patients presenting without persistent ST-segment elevation of the EuropeanSociety of Cardiology (ESC). Eur Heart J 2011;32(23):2999–3054 181. Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, Widimsky P,McCullough PA, Hunt D, Braunwald E, Yusuf S. Routine vs. selective invasive strategiesin patients with acute coronary syndromes: a collaborative meta-analysis ofrandomized trials. JAMA 2005;293(23):2908–2917 182. Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasivetherapy in acute coronary syndromes: a meta-analysis of contemporary randomizedclinical trials. J Am Coll Cardiol 2006;48(7):1319–1325 183. O’Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ,Fox KA, Lagerqvist B, McCullough PA, Murphy SA, Spacek R, Swahn E,Wallentin L,Windhausen F, Sabatine MS. Early invasive vs.conservative treatment strategies inwomen and men with unstable angina and non-ST-segment elevation myocardialinfarction: a meta-analysis. JAMA 2008;300(1):71–80 184. Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, Lagerqvist B,Wallentin L. Long-term outcome of a routine vs. selective invasive strategy inpatients with non-ST-segment elevation acute coronary syndrome a meta-analysisof individual patient data. J Am Coll Cardiol 2010;55(22):2435–2445 185. Katritsis DG, Siontis GC, Kastrati A, van’t Hof AW, Neumann FJ, Siontis KC,Ioannidis JP. Optimal timing of coronary angiography and potential interventionin non-ST-elevation acute coronary syndromes. Eur Heart J 2011;32(1):32–40 186. Navarese EP, Gurbel PA, Andreotti F, Tantry U, Jeong YH, Kozinski M, Engstrom T,Di Pasquale G, Kochman W, Ardissino D, Kedhi E, Stone GW, Kubica J. Optimaltiming of coronary invasive strategy in non-ST-segment elevation acute coronarysyndromes: a systematic review and meta-analysis. Ann Intern Med 2013;158(4):261–270 187. Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R,Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J,Natarajan MK, Horsman C, Fox KA, Yusuf S, Investigators T. Early vs. delayed invasiveintervention in acute coronary syndromes. N Engl J Med 2009;360(21):2165–2175 188. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C,Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, StoneGW. Impact of multivesseldisease on reperfusion success and clinical outcomes in patients undergoingprimary percutaneous coronary intervention for acute myocardial infarction. EurHeart J 2007;28(14):1709–1716 189. Ben-Gal Y, Moses JW, Mehran R, Lansky AJ, Weisz G, Nikolsky E, Argenziano M,Williams MR, Colombo A, Aylward PE, StoneGW. Surgical vs. percutaneous revascularizationfor multivessel disease in patients with acute coronary syndromes: analysisfrom the ACUITY (Acute Catheterization and Urgent Intervention TriageStrategy) trial. JACC Cardiovasc Interv 2010;3(10):1059–1067 190. Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G,Lazar D, Sanchez R, Fahy M, Xu K, Stone GW. Prognostic value of the SYNTAXscore in patients with acute coronary syndromes undergoing percutaneous coronaryintervention: analysis from the ACUITY (Acute Catheterization and UrgentIntervention Triage StrategY) trial. J Am Coll Cardiol 2011;57(24):2389–2397 191. Brener SJ, Milford-Beland S, Roe MT, Bhatt DL, Weintraub WS, Brindis RG Culprit-only or multivessel revascularization in patients with acute coronary syndromes:an American College of Cardiology National Cardiovascular DatabaseRegistry report. Am Heart J 2008;155(1):140–146 192. Hannan EL, Samadashvili Z, Walford G, Jacobs AK, Stamato NJ, Venditti FJ,Holmes DR Jr., Sharma S, King SB 3rd. Staged vs. one-time complete revascularizationwith percutaneous coronary intervention for multivessel coronary arterydisease patients without ST-elevation myocardial infarction. Circ Cardiovasc Interv2013;6(1):12–20 193. Rosner GF, Kirtane AJ, Genereux P, Lansky AJ, Cristea E, Gersh BJ, Weisz G,Parise H, Fahy M, Mehran R, Stone GW. Impact of the presence and extent of incompleteangiographic revascularization after percutaneous coronary interventionin acute coronary syndromes: the Acute Catheterization and Urgent InterventionTriage Strategy (ACUITY) trial. Circulation 2012;125(21):2613–2620 194. Monteiro P. Impact of early coronary artery bypass graft in an unselected acute coronarysyndrome patient population. Circulation 2006;114(1 Suppl):I467–I472 195. Parikh SV, de Lemos JA, Jessen ME, Brilakis ES, Ohman EM, Chen AY, Wang TY,Peterson ED, Roe MT, Holper EM. Timing of in-hospital coronary artery bypassgraft surgery for non-ST-segment elevation myocardial infarction patients resultsfrom the National Cardiovascular Data Registry ACTION Registry-GWTG(Acute Coronary Treatment and Intervention Outcomes Network Registry-GetWith The Guidelines). JACC Cardiovasc Interv 2010;3(4):419–427 196. Greenhalgh J, Hockenhull J, Rao N, Dundar Y, Dickson RC, Bagust A. Drug-elutingstents vs. bare metal stents for angina or acute coronary syndromes. Cochrane DatabaseSyst Rev 2010(5):CD004587 197. Amsterdam EA, Kirk JD, Diercks DB, Lewis WR, Turnipseed SD. Immediate exercisetesting to evaluate low-risk patients presenting to the emergency departmentwith chest pain. J Am Coll Cardiol 2002;40(2):251–256 198. Nyman I,Wallentin L, Areskog M, Areskog NH, Swahn E. Risk stratification by earlyexercise testing after an episode of unstable coronary artery disease. The RISCStudy Group. Int J Cardiol 1993;39(2):131–142 Íå íàøëè, ÷òî èñêàëè? Âîñïîëüçóéòåñü ïîèñêîì:
|